Institute for Behavioral Health
Schneider Institutes for Health Policy
The Heller School for Social Policy and Management at Brandeis University
Aiming to increase recognition of the way behaviors impact health, and to work with systems and organizations to design processes and approaches that improve the overall health of the population.
CONSTANCE M. HORGAN, SC.D.
Since the Heller School began, both faculty and students have studied mental and substance use disorders. Formalized in 2003, IBH focuses on the intersection of health, behavior, and systems of care, with an emphasis on their linkages. Its underlying premise is that these systems can be better used to promote healthier lifestyles and assist individuals to engage in behaviors which lead to better health.
Our focus is broadening to include other issues that are affected by behaviors which can be targeted by interventions and have an impact on health and wellness. In addition to studying systems of care, we investigate health outcomes that are associated with behaviors, and also develop and test methods to evaluate the effects of behaviors on health.
We consider a variety of systems of care, including health care delivery, as well as criminal justice, education, social services, housing, military and the workplace.
We hope that you find this site useful as you learn more about our research staff and our activities in behavioral health.
Researchers at the Institute for Behavioral Health address the Opioid crisis.
Dr. Andrew Kolodny, chief medical officer, Phoenix House and Senior Scientist, Heller School for Social Policy and Management, Brandeis University, joins the panel discussion, ‘New Efforts To Address America’s Growing Addiction Crisis,’ on NPR: Diane Rehm Show, Thursday, Jan 21 2016 • 10 a.m. (ET) https://thedianerehmshow.org/shows/2016-01-21/new-efforts-to-address-americas-growing-addiction-crisis?utm_source=All&utm_campaign=0f909c2b71-
Prescription Behavior Surveillance System (PBSS) data used to identify misuse of opioids as highlighted in this article in the Journal of American Medical Association (JAMA).
Andrew Kolodny, MD., in live interview with C-SPAN host Steve Scully, discusses drug abuse in the U.S.
Controversy surrounding FDA approval of Zohydro. Host David Greene, Dr. Andrew Kolodny, Sr. Researcher at the Institute for Behavioral Health, and other discussants debate opportunities, costs, and unintended consequences. http://www.npr.org/2014/02/26/282836473/critics-question-fdas-approval-of-zoh
In a Washington Post Letter to the Editor, Tom Clark, Manager of the Prescription Drug Monitoring Program's (PDMP) Center of Excellence Clearinghouse, comments on the potential benefits of the PDMP data.
The Bureau of Justice Assistance has partnered with Brandeis (Mary Brolin, PI) to evaluate programs implemented by the Worcester County Sheriff's Office through a newly awarded grant - Second Chance Act "Enhanced Re-entry Program to reduce the recidivism rate of offenders.
IBH & Pew Charitable Trust co-sponsor research forum on state prescription drug monitoring programs.